These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24061455)

  • 1. Cell-free DNA concentration and integrity as a screening tool for cancer.
    Zaher ER; Anwar MM; Kohail HM; El-Zoghby SM; Abo-El-Eneen MS
    Indian J Cancer; 2013; 50(3):175-83. PubMed ID: 24061455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA integrity in plasma and serum of patients with malignant and benign diseases.
    Holdenrieder S; Burges A; Reich O; Spelsberg FW; Stieber P
    Ann N Y Acad Sci; 2008 Aug; 1137():162-70. PubMed ID: 18837942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients.
    Agostini M; Enzo MV; Bedin C; Belardinelli V; Goldin E; Del Bianco P; Maschietto E; D'Angelo E; Izzi L; Saccani A; Zavagno G; Nitti D
    Cancer Biomark; 2012; 11(2-3):89-98. PubMed ID: 23011155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy.
    Agostini M; Pucciarelli S; Enzo MV; Del Bianco P; Briarava M; Bedin C; Maretto I; Friso ML; Lonardi S; Mescoli C; Toppan P; Urso E; Nitti D
    Ann Surg Oncol; 2011 Sep; 18(9):2461-8. PubMed ID: 21416156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis.
    Madhavan D; Wallwiener M; Bents K; Zucknick M; Nees J; Schott S; Cuk K; Riethdorf S; Trumpp A; Pantel K; Sohn C; Schneeweiss A; Surowy H; Burwinkel B
    Breast Cancer Res Treat; 2014 Jul; 146(1):163-74. PubMed ID: 24838941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of plasma cell-free DNA in patients with gastric cancer.
    Sai S; Ichikawa D; Tomita H; Ikoma D; Tani N; Ikoma H; Kikuchi S; Fujiwara H; Ueda Y; Otsuji E
    Anticancer Res; 2007; 27(4C):2747-51. PubMed ID: 17695442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules.
    Szpechcinski A; Rudzinski P; Kupis W; Langfort R; Orlowski T; Chorostowska-Wynimko J
    Cancer Lett; 2016 May; 374(2):202-7. PubMed ID: 26854716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated level of cell-free plasma DNA is associated with breast cancer.
    Zhong XY; Ladewig A; Schmid S; Wight E; Hahn S; Holzgreve W
    Arch Gynecol Obstet; 2007 Oct; 276(4):327-31. PubMed ID: 17431649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
    Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
    Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma DNA integrity in cancer patients.
    Wang BG; Huang HY; Chen YC; Bristow RE; Kassauei K; Cheng CC; Roden R; Sokoll LJ; Chan DW; Shih IeM
    Cancer Res; 2003 Jul; 63(14):3966-8. PubMed ID: 12873992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations.
    Pinzani P; Salvianti F; Zaccara S; Massi D; De Giorgi V; Pazzagli M; Orlando C
    Clin Chim Acta; 2011 Nov; 412(23-24):2141-5. PubMed ID: 21839068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of breast tumor progression by integrity of free circulating DNA in serum.
    Umetani N; Giuliano AE; Hiramatsu SH; Amersi F; Nakagawa T; Martino S; Hoon DS
    J Clin Oncol; 2006 Sep; 24(26):4270-6. PubMed ID: 16963729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total serum DNA and DNA integrity: diagnostic value in patients with hepatitis B virus-related hepatocellular carcinoma.
    Chen H; Sun LY; Zheng HQ; Zhang QF; Jin XM
    Pathology; 2012 Jun; 44(4):318-24. PubMed ID: 22531347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer.
    Tomita H; Ichikawa D; Ikoma D; Sai S; Tani N; Ikoma H; Fujiwara H; Kikuchi S; Okamoto K; Ochiai T; Otsuji E
    Anticancer Res; 2007; 27(4C):2737-41. PubMed ID: 17695440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease.
    Szpechcinski A; Chorostowska-Wynimko J; Struniawski R; Kupis W; Rudzinski P; Langfort R; Puscinska E; Bielen P; Sliwinski P; Orlowski T
    Br J Cancer; 2015 Jul; 113(3):476-83. PubMed ID: 26125447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.
    Kamat AA; Sood AK; Dang D; Gershenson DM; Simpson JL; Bischoff FZ
    Ann N Y Acad Sci; 2006 Sep; 1075():230-4. PubMed ID: 17108216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection.
    Wu X; Tanaka H
    Oncotarget; 2015 Oct; 6(30):29795-807. PubMed ID: 26356673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of plasma cfDNA concentration and integrity in breast cancer patients.
    Miao Y; Fan Y; Zhang L; Ma T; Li R
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):64-72. PubMed ID: 31472049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients.
    Benesova L; Belsanova B; Suchanek S; Kopeckova M; Minarikova P; Lipska L; Levy M; Visokai V; Zavoral M; Minarik M
    Anal Biochem; 2013 Feb; 433(2):227-34. PubMed ID: 22750103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.